News
ASCO 2025 overall survival data bolster IMNN-001's potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback